Literature DB >> 21149601

Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling.

Katherine C MacNamara1, Kwadwo Oduro, Olga Martin, Derek D Jones, Maura McLaughlin, Kyunghee Choi, Dori L Borjesson, Gary M Winslow.   

Abstract

Although microbial infections can alter steady-state hematopoiesis, the mechanisms that drive such changes are not well understood. We addressed a role for IFN-γ signaling in infection-induced bone marrow suppression and anemia in a murine model of human monocytic ehrlichiosis, an emerging tick-borne disease. Within the bone marrow of Ehrlichia muris-infected C57BL/6 mice, we observed a reduction in myeloid progenitor cells, as defined both phenotypically and functionally. Infected mice exhibited a concomitant increase in developing myeloid cells within the bone marrow, an increase in the frequency of circulating monocytes, and an increase in splenic myeloid cells. The infection-induced changes in progenitor cell phenotype were critically dependent on IFN-γ, but not IFN-α, signaling. In mice deficient in the IFN-γ signaling pathway, we observed an increase in myeloid progenitor cells and CDllb(lo)Gr1(lo) promyelocytic cells within the bone marrow, as well as reduced frequencies of mature granulocytes and monocytes. Furthermore, E. muris-infected IFN-γR-deficient mice did not exhibit anemia or an increase in circulating monocytes, and they succumbed to infection. Gene transcription studies revealed that IFN-γR-deficient CDllb(lo)Gr1(lo) promyelocytes from E. muris-infected mice exhibited significantly reduced expression of irf-1 and irf-8, both key transcription factors that regulate the differentiation of granulocytes and monocytes. Finally, using mixed bone marrow chimeric mice, we show that IFN-γ-dependent infection-induced myelopoiesis occurs via the direct effect of the cytokine on developing myeloid cells. We propose that, in addition to its many other known roles, IFN-γ acts to control infection by directly promoting the differentiation of myeloid cells that contribute to host defense.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149601      PMCID: PMC3178067          DOI: 10.4049/jimmunol.1001893

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Identification of clonogenic common lymphoid progenitors in mouse bone marrow.

Authors:  M Kondo; I L Weissman; K Akashi
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

2.  IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity.

Authors:  Tomohiko Tamura; Prafullakumar Tailor; Kunihiro Yamaoka; Hee Jeong Kong; Hideki Tsujimura; John J O'Shea; Harinder Singh; Keiko Ozato
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

3.  Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.

Authors:  M Schmidt; S Nagel; J Proba; C Thiede; M Ritter; J F Waring; F Rosenbauer; D Huhn; B Wittig; I Horak; A Neubauer
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

4.  Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene.

Authors:  T Holtschke; J Löhler; Y Kanno; T Fehr; N Giese; F Rosenbauer; J Lou; K P Knobeloch; L Gabriele; J F Waring; M F Bachmann; R M Zinkernagel; H C Morse; K Ozato; I Horak
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

5.  Hematopoietic remodeling in interferon-gamma-deficient mice infected with mycobacteria.

Authors:  P J Murray; R A Young; G Q Daley
Journal:  Blood       Date:  1998-04-15       Impact factor: 22.113

6.  Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs.

Authors:  C Cheers; A M Haigh; A Kelso; D Metcalf; E R Stanley; A M Young
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

7.  The Ly-6E.1 (Sca-1) gene requires a 3' chromatin-dependent region for high-level gamma-interferon-induced hematopoietic cell expression.

Authors:  A Sinclair; B Daly; E Dzierzak
Journal:  Blood       Date:  1996-04-01       Impact factor: 22.113

8.  Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow.

Authors:  Yoshihiro Ueda; Motonari Kondo; Garnett Kelsoe
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

9.  Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.

Authors:  Y Y Zhang; T A Vik; J W Ryder; E F Srour; T Jacks; K Shannon; D W Clapp
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

10.  Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT enhancer binding protein alpha (C/EBP alpha) is critical for granulopoiesis.

Authors:  P Zhang; A Iwama; M W Datta; G J Darlington; D C Link; D G Tenen
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

View more
  64 in total

1.  Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-γ.

Authors:  Luigi J Alvarado; Heather D Huntsman; Hai Cheng; Danielle M Townsley; Thomas Winkler; Xingmin Feng; Cynthia E Dunbar; Neal S Young; Andre Larochelle
Journal:  Blood       Date:  2019-02-25       Impact factor: 22.113

2.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 3.  TLRs control hematopoiesis during infection.

Authors:  Alberto Yáñez; Helen S Goodridge; Daniel Gozalbo; M Luisa Gil
Journal:  Eur J Immunol       Date:  2013-10       Impact factor: 5.532

4.  CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells.

Authors:  Govindhasamy Pushpavathi Selvakumar; Mohammad Ejaz Ahmed; Sudhanshu P Raikwar; Ramasamy Thangavel; Duraisamy Kempuraj; Iuliia Dubova; Daniyal Saeed; Haris Zahoor; Keerthivaas Premkumar; Smita Zaheer; Shankar Iyer; Asgar Zaheer
Journal:  J Neuroimmune Pharmacol       Date:  2019-02-27       Impact factor: 4.147

5.  Macrophage-Lineage Cells Negatively Regulate the Hematopoietic Stem Cell Pool in Response to Interferon Gamma at Steady State and During Infection.

Authors:  Amanda McCabe; Yubin Zhang; Vinh Thai; Maura Jones; Michael B Jordan; Katherine C MacNamara
Journal:  Stem Cells       Date:  2015-05-22       Impact factor: 6.277

Review 6.  Inflammation: a key regulator of hematopoietic stem cell fate in health and disease.

Authors:  Eric M Pietras
Journal:  Blood       Date:  2017-09-05       Impact factor: 22.113

Review 7.  The Regulatory Role of IFN-γ on the Proliferation and Differentiation of Hematopoietic Stem and Progenitor Cells.

Authors:  Yuhong Qin; Cai Zhang
Journal:  Stem Cell Rev Rep       Date:  2017-12       Impact factor: 5.739

8.  IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure.

Authors:  Jichun Chen; Xingmin Feng; Marie J Desierto; Keyvan Keyvanfar; Neal S Young
Journal:  Blood       Date:  2015-10-21       Impact factor: 22.113

9.  MyD88 signaling in CD4 T cells promotes IFN-γ production and hematopoietic progenitor cell expansion in response to intracellular bacterial infection.

Authors:  Yubin Zhang; Maura Jones; Amanda McCabe; Gary M Winslow; Dorina Avram; Katherine C MacNamara
Journal:  J Immunol       Date:  2013-03-22       Impact factor: 5.422

10.  An Atypical Splenic B Cell Progenitor Population Supports Antibody Production during Plasmodium Infection in Mice.

Authors:  Debopam Ghosh; Daniel J Wikenheiser; Brian Kennedy; Kathryn E McGovern; Johnasha D Stuart; Emma H Wilson; Jason S Stumhofer
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.